We are live on
!
Find out more
JSP
Jackson Square Partners Portfolio holdings
AUM
$247M
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter
Est. Return
+13.07%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$3.75B
AUM Growth
-$62.6M
(-1.6%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-10.55%
Top 10 Holdings %
Top 10 Hldgs %
44.95%
Holding
93
New
10
Increased
14
Reduced
56
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lattice Semiconductor
LSCC
|
+$65.1M |
| 2 |
Okta
OKTA
|
+$48.6M |
| 3 |
SiteOne Landscape Supply
SITE
|
+$46M |
| 4 |
FMC
FMC
|
+$38.5M |
| 5 |
Grocery Outlet
GO
|
+$30.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$106M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$105M |
| 3 |
Upwork
UPWK
|
+$96.4M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$48.6M |
| 5 |
Pacific Biosciences
PACB
|
+$45.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Industrials | 20.06% |
| 3 | Healthcare | 19.45% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 10.75% |
Similar funds
OIA
SRC
TCB
MTWM
SSW
WS
FC
KSWA
Jackson Square Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Jackson Square Partners held 93 positions worth $3.75B, down 1.6% from $3.81B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jackson Square Partners withdrew a net $395M in Q4 2022, closing 12 positions and reducing 56 holdings. Its most notable exit was CATALENT, INC., an estimated $106M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Jackson Square Partners opened a new position in Lattice Semiconductor worth $70M.
- Jackson Square Partners's largest Q4 2022 buy was Lattice Semiconductor: 1,078,759 shares worth $70M.
- Jackson Square Partners added most to SiteOne Landscape Supply in Q4 2022, an estimated $46M increase.
- Jackson Square Partners's biggest Q4 2022 reduction was Pacific Biosciences, cutting an estimated $45.3M.
- Jackson Square Partners fully exited CATALENT, INC. in Q4 2022, selling an estimated $106M.
- Jackson Square Partners's ten largest holdings make up 45% of its $3.75B portfolio in Q4 2022.
- Jackson Square Partners opened 10 new positions and closed 12 in Q4 2022.
- Jackson Square Partners's portfolio value fell 1.6% quarter-over-quarter to $3.75B.
Based on Jackson Square Partners's 13F filing for Q4 2022, filed 9 Feb 2023.